Published in Br J Cancer on October 01, 1984
Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor. Proc Natl Acad Sci U S A (1986) 1.28
Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination. Clin Exp Immunol (1986) 1.12
Effects of airway exposure to nanoparticles on lung inflammation induced by bacterial endotoxin in mice. Environ Health Perspect (2006) 0.99
An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42
Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun (1980) 3.41
Sensitivity of mice to endotoxin after vaccination with BCG (Bacillus Calmette-Guérin). Proc Soc Exp Biol Med (1958) 3.39
Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties. Br J Cancer (1978) 3.38
Vascular reactions of normal and malignant tissues in vivo. V. The rôle of hypotension in the action of a bacterial polysaccharide on tumors. J Natl Cancer Inst (1952) 2.81
Tumour-necrosis factor from the rabbit. II. Production by monocytes. Br J Cancer (1978) 2.48
Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells. J Immunol (1975) 2.46
Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice. J Immunol (1979) 1.48
Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro. Jpn J Exp Med (1981) 1.45
Tumor necrosis factor. Clin Bull (1976) 1.36
Tumor regression caused by endotoxins and mycobacterial fractions. J Natl Cancer Inst (1975) 1.17
Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. J Immunol (1979) 1.07
The reticuloendothelial system and the neoplastic process. Ann N Y Acad Sci (1960) 1.03
Defective tumoricidal capacity of macrophages from A/J mice. III. Genetic analysis of the macrophage defect. J Immunol (1980) 1.02
Research on the production site of tumor necrosis factor (TNF). Jpn J Exp Med (1981) 0.88
Dose, route, and time dependence of serum lysozyme and antitumor activity following administration of glucan, Corynebacterium parvum, pyran, or lipopolysaccharide to mice. J Natl Cancer Inst (1981) 0.79
The DWF4 gene of Arabidopsis encodes a cytochrome P450 that mediates multiple 22alpha-hydroxylation steps in brassinosteroid biosynthesis. Plant Cell (1998) 3.86
The Arabidopsis deetiolated2 mutant is blocked early in brassinosteroid biosynthesis. Plant Cell (1997) 3.00
Transcription of the Arabidopsis CPD gene, encoding a steroidogenic cytochrome P450, is negatively controlled by brassinosteroids. Plant J (1998) 2.57
Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med (1991) 2.17
p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males. Eur J Neurol (2013) 2.11
Structure of rhodotorucine A, a novel lipopeptide, inducing mating tube formation in Rhodosporidium toruloides. Biochem Biophys Res Commun (1978) 1.74
Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J Natl Cancer Inst (1986) 1.68
Arabidopsis det2 is defective in the conversion of (24R)-24-methylcholest-4-En-3-one to (24R)-24-methyl-5alpha-cholestan-3-one in brassinosteroid biosynthesis. Plant Physiol (1999) 1.66
Brassinosteroids. Nat Prod Rep (1997) 1.65
Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer (1984) 1.57
A synthetic peptide substrate for selective assay of protein kinase C. Biochem Biophys Res Commun (1990) 1.54
Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro. Jpn J Exp Med (1981) 1.45
Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-beta gene. J Clin Endocrinol Metab (1992) 1.40
Deterioration of rheumatoid arthritis with troglitazone: a rare and unexpected adverse effect. Arch Intern Med (2000) 1.39
Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease. J Clin Endocrinol Metab (1992) 1.38
Characterization of a thyroid hormone receptor expressed in human kidney and other tissues. Proc Natl Acad Sci U S A (1988) 1.33
Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor. Proc Natl Acad Sci U S A (1986) 1.28
FDG PET measurement of the proliferative potential of non-small cell lung cancer. J Nucl Med (2000) 1.26
Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophages. J Natl Cancer Inst (1985) 1.25
Identification of castasterone, 6-deoxocastasterone, typhasterol and 6-deoxotyphasterol from the shoots of Arabidopsis thaliana. Plant Cell Physiol (1996) 1.19
Metabolites of mating pheromone, rhodotorucine A, by a cells of Rhodosporidium toruloides. Biochem Biophys Res Commun (1980) 1.18
Frontoorbital advancement by gradual distraction. Technical note. J Neurosurg (1998) 1.17
Uniaxial tension inhibits tendon collagen degradation by collagenase in vitro. J Orthop Res (1996) 1.16
Mating reaction in Saccharomyces cerevisiae. IX. Regulation of sexual cell agglutinability of a type cells by a sex factor produced by alpha type cells. Arch Microbiol (1976) 1.16
Characterization of a third human thyroid hormone receptor coexpressed with other thyroid hormone receptors in several tissues. Mol Endocrinol (1988) 1.16
Gradual cranial vault expansion for the treatment of craniofacial synostosis: a preliminary report. Ann Plast Surg (1998) 1.16
Purification and partial amino acid sequence of rabbit tumor necrosis factor. Int J Cancer (1985) 1.14
Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer. Eur J Nucl Med (2000) 1.10
A human early response gene homologous to murine nur77 and rat NGFI-B, and related to the nuclear receptor superfamily. Mol Endocrinol (1990) 1.10
FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features. Nucl Med Commun (2000) 1.06
Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity. J Clin Endocrinol Metab (1997) 1.05
Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy. Gut (1990) 1.03
Exercise effects on methylation of ASC gene. Int J Sports Med (2010) 1.02
Cotylenin A, a plant-growth regulator, induces the differentiation in murine and human myeloid leukemia cells. Biochem Biophys Res Commun (1997) 1.02
[Structure of urothion]. J Biochem (1969) 1.00
[Synthesis of urothion]. J Biochem (1969) 0.99
Screening of nineteen unrelated families with generalized resistance to thyroid hormone for known point mutations in the thyroid hormone receptor beta gene and the detection of a new mutation. J Clin Invest (1991) 0.98
The retroesophageal subclavian artery--a case report and review. Kaibogaku Zasshi (1993) 0.97
Bunina bodies in amyotrophic lateral sclerosis immunostained with rabbit anti-cystatin C serum. Neurosci Lett (1993) 0.96
Correlation of axillary osmidrosis to a SNP in the ABCC11 gene determined by the Smart Amplification Process (SmartAmp) method. J Plast Reconstr Aesthet Surg (2009) 0.94
Structure of aspochracin, an insecticidal metabolite of Aspergillus ochraceus. Tetrahedron Lett (1969) 0.94
Enhanced sensitivity to alkylating agent in lymphocytes from patients with multiple endocrine neoplasia type 1. Biomed Pharmacother (2000) 0.92
Cyclophilin A-independent replication of a human immunodeficiency virus type 1 isolate carrying a small portion of the simian immunodeficiency virus SIV(MAC) gag capsid region. J Virol (2001) 0.92
Hyperfunctioning thyroid adenoma concomitant with papillary thyroid carcinoma, follicular thyroid adenoma and primary hyperparathyroidism. Endocr J (1998) 0.92
Correlation of Glut-1 glucose transporter expression with. Eur J Nucl Med (2000) 0.92
Role of lipid A in the production of tumor necrosis factor and differences in antitumor activity between tumor necrosis factor and lipopolysaccharide. Tohoku J Exp Med (1984) 0.90
Combination therapy of anti-endotoxin antibody and gentamicin in the immunosuppressed mice with Pseudomonas aeruginosa infection. Jpn J Exp Med (1975) 0.90
Research on the production site of tumor necrosis factor (TNF). Jpn J Exp Med (1981) 0.88
A new approach for improving cordycepin productivity in surface liquid culture of Cordyceps militaris using high-energy ion beam irradiation. Lett Appl Microbiol (2008) 0.87
Reduction of mental stress with lavender odorant. Percept Mot Skills (2001) 0.87
Role of first stimulating agents in the production of tumor necrosis factor. Cancer Immunol Immunother (1984) 0.87
DIF-1, morphogen of Dictyostelium discoideum, induces the erythroid differentiation in murine and human leukemia cells. Biochem Biophys Res Commun (1995) 0.86
Changes in coagulative and fibrinolytic activities in patients with intracranial hemorrhage. Acta Neurochir Suppl (2006) 0.86
Identification of two novel mutations in the OCRL1 gene in Japanese families with Lowe syndrome. Clin Genet (1998) 0.86
Cell-dependent gag mutants of HIV-1 are crucially defective at the stage of uncoating/reverse transcription in non-permissive cells. Microbes Infect (2000) 0.85
Preventive effects of several chemicals against lethality of recombinant human tumor necrosis factor. J Biol Response Mod (1988) 0.85
Painful bipartite patella in young athletes. The diagnostic value of skyline views taken in squatting position and the results of surgical excision. Clin Orthop Relat Res (1994) 0.85
Endotoxin-induced tumor necrosis factor. Recent Results Cancer Res (1980) 0.84
Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. Cancer Immunol Immunother (1985) 0.83
Neopterin: isolation from human urine. J Biochem (1967) 0.83
Tumor necrosis factor enhances GD3 ganglioside expression in cultured human melanocytes. Arch Biochem Biophys (1990) 0.83
Antitumor activity of combination therapy with traditional Chinese medicine and OK432 or MMC. J Biol Response Mod (1988) 0.82
Interspecific actions of alpha mating pheromones on the a mating-type cells of three Saccharomyces yeasts. Curr Genet (1988) 0.82
Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy. J Biol Response Mod (1987) 0.82
Reconstruction of skull defects with vascularized omentum transfer and split calvarial bone graft: two case reports. J Reconstr Microsurg (1998) 0.82
Proliferation-associated expression of the MEN1 gene as revealed by in situ hybridization: possible role of the menin as a negative regulator of cell proliferation under DNA damage. Lab Invest (2000) 0.82
Effects of selenium deficiency on expression of selenoproteins in bovine arterial endothelial cells. Biol Pharm Bull (2001) 0.81
Lupus vulgaris of the earlobe. Ann Plast Surg (1997) 0.81
Expression of multidrug resistance protein and messenger RNA correlate with (99m)Tc-MIBI imaging in patients with lung cancer. J Nucl Med (2001) 0.81
Two thyroid hormone response elements are present in the promoter of human thyroid hormone receptor beta 1. Mol Endocrinol (1994) 0.81
Importance of cerebral perfusion pressure management using cerebrospinal drainage in severe traumatic brain injury. Acta Neurochir Suppl (2006) 0.81
Necrotizing activity of tumor necrosis factor: histopathological investigation using Meth A sarcoma and granulation tissue. Virchows Arch B Cell Pathol Incl Mol Pathol (1987) 0.81
Inhibition of tumor-induced migration of bovine capillary endothelial cells by mouse and rabbit tumor necrosis factor. J Natl Cancer Inst (1987) 0.81
Fragmentation of the Golgi apparatus of the anterior horn cells in patients with familial amyotrophic lateral sclerosis with SOD1 mutations and posterior column involvement. J Neurol Sci (2000) 0.81
Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas. Horm Metab Res (2001) 0.80